Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
about
Aripiprazole: from pharmacological profile to clinical useCombination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance.Can valproic acid be an inducer of clozapine metabolism?Clinical pharmacology of atypical antipsychotics: an update.Role of aripiprazole in treating mood disorders.Metabolic drug interactions with newer antipsychotics: a comparative review.A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder.Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients.A UK consensus on the administration of aripiprazole for the treatment of mania.Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder.Aripiprazole: a review of its use in the management of schizophrenia in adults.Interactions between antiepileptics and second-generation antipsychotics.Aripiprazole: a review of its use in the treatment of irritability associated with autistic disorder patients aged 6-17.Clinically significant drug interactions with atypical antipsychotics.Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics.Dosing Recommendations of Aripiprazole Depot with Strong Cytochrome P450 3A4 Inhibitors: A Relapse Risk.Three patients needing high doses of valproic Acid to get therapeutic concentrationsTreatment and prevention of mania in bipolar I disorder: focus on aripiprazole.Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans.
P2860
Q26778312-581DC4D7-5FBD-4D22-907A-70B4AAF03144Q34297422-DD272830-0859-42C0-AA74-2EC7653F199DQ34497477-5FA91F8C-527D-4ADF-AF34-1C03EDFE7ECDQ35728228-69247E18-D159-4350-B5B6-923A5AD9D684Q36688973-3BF064F3-96C5-47C1-B305-2254332762EEQ36703845-F12A1FA4-1732-41DB-B262-428E708A2BFFQ37166131-061E94E4-9DFC-45BD-9787-0C89D8D6A45CQ37175786-D4F70AEF-D16B-4EC3-9537-31C2C5E54C68Q37326130-A31AF81A-8787-4E64-8B3A-2193BAEBED80Q37970762-37DC98F7-08C2-43D1-B8FD-7F75D3468E7FQ37980517-DFE0B174-773D-43BF-809A-9888B0222B1BQ37983921-C88EC1AE-AFEE-46BA-9742-3714CC38F469Q38122151-EAB53FF7-51AF-46EF-8FB6-1CDADB9DCF07Q38156416-C0A40608-ED47-49EE-A651-49A0796A197AQ38734067-B8676277-BAB8-4DCF-9A8A-961100B9C8BCQ39284573-5C7416D1-9995-4966-ABCA-8DEC267833BBQ40523894-238C2A13-B691-4D43-85F7-7418785E4759Q41528294-F7BC1C58-7469-4982-A59F-A130B5D5DFB5Q48318789-A01A4F43-154A-4A24-9C2A-48BDB21C3330
P2860
Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
@ast
Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
@en
Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
@nl
type
label
Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
@ast
Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
@en
Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
@nl
prefLabel
Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
@ast
Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
@en
Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
@nl
P2093
P2860
P356
P1476
Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
@en
P2093
Daniel E Salazar
Nigel Bark
Richard Josiassen
Suresh Mallikaarjun
P2860
P356
10.1177/0091270004269870
P577
2005-01-01T00:00:00Z